---
schema_version: "secwatch.filing_event.v1"
accession: "0001815776-25-000036"
form_type: "8-K"
ticker: "LENZ"
cik: "0001815776"
company_name: "LENZ Therapeutics, Inc."
filed_at: "2025-06-10T23:59:59+00:00"
generated_at: "2026-05-19T15:58:31.658895+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# LENZ Therapeutics annual meeting elects directors, ratifies auditor

## Summary
- 17,983,676 of 27,544,520 shares represented at June 10, 2025 annual meeting.
- Class III directors Kimberlee C. Drapkin and Zach Scheiner elected with ~12.4M and ~12.7M votes for.
- Class I directors Frederic Guerard and James McCollum elected with ~15.4M and ~15.4M votes for.
- Ernst & Young LLP ratified as independent auditor for FY2025 with 17,979,770 votes for.
- No proposals or business items beyond standard director elections and auditor ratification.

## SEC filing metadata
- accession: 0001815776-25-000036
- form_type: 8-K
- ticker: LENZ
- cik: 0001815776
- company_name: LENZ Therapeutics, Inc.
- filed_at: 2025-06-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1815776/000181577625000036/0001815776-25-000036-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1815776/000181577625000036/lenz-20250610.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001815776-25-000036
- JSON: https://secwatch.observer/filing/0001815776-25-000036.json
- Plain text: https://secwatch.observer/filing/0001815776-25-000036.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.